MD Newsline

In this episode of MD Newsline, Dr. Rachael Sood, a diabetes nurse practitioner and certified diabetes care and education specialist from New Orleans, Louisiana, shares her insights from the 85th American Diabetes Association Scientific Sessions. As the founder of The Diabetes Collective, Dr. Sood discusses the evolution of diabetology—a specialized field focused solely on the identification, treatment, and management of diabetes across all patient populations.

/episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/38560080

In this episode of MD Newsline, Dr. Martin Kaiser, Consultant Hematologist at the Royal Marsden Hospital and Professor of Hematology at the Institute of Cancer Research, London, discusses groundbreaking advances in the diagnosis and management of high-risk multiple myeloma. Drawing insights from the OptiMUM trial and related studies, Dr. Kaiser explores how genetic profiling, long-term treatment intensity, and personalized approaches are transforming patient outcomes. He also examines the challenges of t /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/38559980

Dr. Litzow shares deep /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/38559940

In this episode of MD Newsline, Dr. Sassan Mirfakhraee, adult endocrinologist and associate professor at the University of Texas Southwestern Medical Center, shares groundbreaking insights into the management of adrenal insufficiency. At the Endocrine 2025 conference, Dr. Mirfakhraee presented his research on utilizing insulin pumps to deliver hydrocortisone—an innovative off-label approach that is showing promising results for patients who remain symptomatic on oral therapy.

He explains how thi /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/38467770

She explains how endocrine therapies currently used to block estrogen signaling often worsen bone fragility, leading t /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37849295

In this episode of MD Newsline, Dr. Andreas Hochhaus, Professor of Internal Medicine, Hematology, and Oncology at the Comprehensive Cancer Center in Jena, Germany, shares his expertise on the evolution of chronic myeloid leukemia (CML) therapies. He reflects on decades of progress in CML treatment, from interferon to targeted TKIs, and highlights the importance of tolerability, patient-centered care, and innovative trial data shaping the future of CML management.

/episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37849190

In this episode of MD Newsline, Dr. Eleonora Teplinksy, a breast and gynecologic medical oncologist at Valley Health System and clinical assistant professor at the Icahn School of Medicine at Mount Sinai, shares key updates from the ASCO annual meeting. She discusses transformative clinical trials that are reshaping the landscape of metastatic breast cancer treatment across subtypes including hormone r /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37618515

In this episode of MD Newsline, Dr. Ashley Sumrall, a neuro-oncologist and Section Chief at Atrium Health Levine Cancer Institute, shares groundbreaking insights into the treatment of diffuse midline gliomas with the H3K27M mutation. Dr. Sumrall presents data from pediatric and adult studies using Dordaviprone (ONC201), highlighting its promising response rates and tolerability. She also discusses the /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37618470

In this episode of MD Newsline, Dr. Karine Tawagi, a genitourinary medical oncologist at the University of Illinois in Chicago, shares cutting-edge updates from ASCO 2024 related to bladder, prostate, and kidney cancers. Dr. Tawagi explores the clinical implications of circulating tumor DNA (CT DNA), discusses evolving bladder preservation strategies, and addresses the expanding role of PARP inhibitors /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37468810

In this episode of MD Newsline, we welcome Peixuan Zheng, an exercise scientist at the University of Illinois Chicago, who shares her research on using step-based physical activity metrics to assess and enhance the daily function of individuals with multiple sclerosis (MS). Peixuan discusses how wearable technology and new step-counting methods—like peak cadence—can provide more accurate insights into patients' real-world mobility compared to traditional clinical assessments.

She also dives in /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37468795

In this episode of MD Newsline, Dr. Alice Edward, a pediatric and adult neurologist and neuroimmunology specialist, explores the complex landscape of diagnosing and managing multiple sclerosis (MS) in children. She highlights the critical differences between pediatric and adult MS, including symptom presentation, diagnostic criteria, and treatment strategies. Dr. Edward also delves into the impact of hormonal changes, pregnancy planning, and the challenges of transitioning care from pediatric to adult ne /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37468750

In this episode of MD Newsline, Dr. Michael Robers, a neurologist and multiple sclerosis (MS) specialist at Barrow Neurological Institute in Phoenix, Arizona, shares groundbreaking research on the intersection of hypertension and MS. He highlights the high prevalence of undiagnosed hypertension among MS patients and its association with worse physical disability. Dr. Robers also explores systemic care gaps and advocates for a more integrated, whole-person approach to MS care—emphasizing the role of MS /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37360115

In this episode of MD Newsline, Dr. Olivia Wills and Karen Zoczak—accredited practicing dietitians and researchers from Australia—explore the evolving role of dietetics in multiple sclerosis (MS) care. Recorded at a global MS conference, the discussion spotlights the importance of individualized dietary support as part of a comprehensive, multidisciplinary care plan. Dr. Wills and Ms. Zoczak share /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37360035

In this episode of MD Newsline, Dr. Sarimar Agosto Salgado, Oncologic Endocrinologist at Moffitt Cancer Center, shares insights from a panel discussion at the AACE 2025 conference on the complexities of advanced thyroid cancer. She explores case-based approaches to recurrent, radioactive iodine-refractory disease and introduces the evolving strategy of re-differentiation therapy—a promising method for resensitizing tumors to radioactive iodine.

Dr. Salgado also highlights real-world challenges i /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37359875

In this episode of MD Newsline, Dr. Omolara G. Adeniran, an endocrinologist practicing in Florida, shares her frontline experience addressing the complex realities of diabetes management, technology hesitancy, and healthcare disparities. Drawing on insights from the American Association of Clinical Endocrinology (AACE) conference, Dr. Adeniran discusses lipodystrophy, CGM technology, and how to navigate social determinants of health in real-world patient care.

/episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37288135

In this episode of MD Newsline, Dr. Kamrun Naher, an endocrinologist based in Brooklyn, shares two compelling case studies that highlight how seemingly psychiatric symptoms and subtle complaints can conceal serious endocrine disorders. She recounts a rare case where suicidal behavior and insomnia led to the discovery of a neuroendocrine tumor in the pancreas, as well as a cluster of unexpected diagnoses of pheochromocytoma—a rare tumor of the adrenal glands.

Dr. Naher underscores the need for mu /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37288120

In this episode of MD Newsline, Dr. Elias Jabbour, Professor of Medicine at MD Anderson Cancer Center, shares groundbreaking insights into the evolving treatment landscape of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML). He discusses the transformative role of tyrosine kinase inhibitors (TKIs), strategies to achieve treatment-free remission, and how genetic testing, CAR-T therapy, and monoclonal antibodies are reshaping frontline and relapsed leukem /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37281715

In this episode of MD Newsline, Dr. Jamie Almandoz, Associate Professor at UT Southwestern Medical Center and Medical Director of the Weight Wellness and Obesity Medicine Program, discusses the evolving science of post-bariatric weight management, the rising use of GLP-1 medications, and the role of multidisciplinary care in treating obesity as a chronic illness. He shares practical insights into weight regain after bariatric surgery, how medications can support long-term outcomes, and the importance of /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/37157365

In this episode of MD Newsline, Dr. Beth Malow, a professor of neurology and pediatrics at Vanderbilt University Medical Center, shares her unique perspective on the intersections of climate change, sleep health, and brain health. She explores how environmental factors like air pollution and extreme heat can worsen conditions such as autism, dementia, stroke, and sleep disorders, while also discussing the importance of interdisciplinary research, science communication, and patient advocacy in mitigating /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/36743625

In this episode of MD Newsline, Dr. Jennifer Vermillion, assistant professor of neurology and pediatrics at the University of Rochester, shares her insights into pediatric movement disorders and rare neurodegenerative diseases, including Tourette syndrome and Batten disease (NCLs). She discusses how early diagnosis, genetic research, and advances in treatment—including gene therapy—are reshaping outcomes for children with these conditions. Dr. Vermillion also emphasizes the role of natural history st /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/36743680

In this episode of MD Newsline, hepatologist Dr. Steven Flamm (Northwestern Medicine) demystifies the spectrum of metabolic-associated fatty liver disease—from the highly prevalent MASLD (metabolic-associated steatotic liver disease) to its inflammatory form, MASH (metabolic-associated steatohepatitis). Dr. Flamm details who is at risk, why only a subset progress to fibrosis and cirrhosis, and how clinicians can intervene early with lifestyle, pharmacologic, and procedural tools. He also reviews the fi /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/36743535

In this episode of MD Newsline, Dr. Stacey Clardy, a neurologist at the University of Utah and the Salt Lake City VA, shares her expertise in autoimmune neurology, focusing on autoimmune encephalitis—a complex, often misunderstood condition where the immune system attacks the brain. Dr. Clardy explains how symptoms often mimic psychiatric disorders, complicating timely diagnosis and treatment. She also discusses the Extinguish Trial, a groundbreaking NIH-supported clinical study testi /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/36611070

In this episode of MD Newsline, Dr. Janelle Duah, a specialist in internal medicine, obesity, and lifestyle medicine, discusses the evolving understanding of obesity as a chronic disease rather than a personal failing. She explains the neurobiological, physiological, psychological, and environmental factors that contribute to weight gain, highlighting why traditional methods of diet and exercise alone often fail. Dr. Duah also explores the latest FDA-approved weight loss medications, th /episode/index/show/ecb5ed55-2779-489f-bef7-9484228289f1/id/35864935